Webinar: Part 2: Mid-career Muddle: From Stagnation to Success
As the second installment in a three-part webinar series led by the Women's Initiative Committee (WIC), this session explores...
AASLD Announces Update to Metabolic Dysfunction‐Associated Steatotic Liver Disease (MASLD) Practice Guidance
New guidance provides clinicians with practical, evidence-based criteria for patient selection, comorbidity management, and...
Statement from AASLD: AASLD Acknowledges Withdrawal of Obeticholic Acid for Primary Biliary Cholangitis and Announces Upcoming Guideline Update
The American Association for the Study of Liver Diseases (AASLD) acknowledges the recent market withdrawal of obeticholic acid...
Basic Science Emerging Topic Conference: The LiverLink: Unraveling Systems Biology in Pathogenesis and Treatment of Liver Disease
Program Chairs: Savneet Kaur, PhD; Cristina Llorente, PhD; Marti Ortega Ribera, PhD
Taking place at DDW 2026, May 2-3, this two...
AASLD Announces New Practice Guideline on Treatment of Chronic Hepatitis B
The American Association for the Study of Liver Diseases (AASLD) and the Infectious Diseases Society of America (IDSA) are...
Resmetirom and Semaglutide for MASH in 2025: Updated recommendations from AASLD Guidance
Moderator: Robert Fontana
This session will address MASLD/ MASH 2025 needs regarding available treatment options for MASLD...
Digestive Disease Week® 2026
For more event information, please visit here.
Hepatitis B
AASLD develops evidence-based practice guidelines which are updated regularly by a multi-disciplinary panel of experts, including hepatologists, and include recommendations of preferred approaches to the diagnostic, therapeutic, and preventive aspects of care. AASLD also provides practice tools to assist with learning and implementing the new recommendations.